MEDICINOVA INC (MNOV) Earnings History & Surprises

NASDAQ:MNOV • US58468P2065

1.36 USD
+0.06 (+4.62%)
Last: Mar 6, 2026, 08:00 PM

Past quarterly earnings results for MEDICINOVA INC (MNOV), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).

Earnings Snapshot

Next Earnings Date

Upcoming
Release DateMay 11, 2026
PeriodQ4 / 2025
EPS Estimate-$0.10
Revenue Estimate

Last Reported

Most Recent
Release DateFeb 13, 2026
PeriodQ3 / 2025
EPS Reported-$0.06
EPS Surprise 41.18%
Revenue Surprise %

Beat Rate

Last 8 Quarters
38%
EPS and Revenuebeats vs estimates

Quarterly Earnings Results

EPS & Revenue History (USD)

Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.

QuarterEPSEPS EstEPS SurpriseEPS Q2QRevenueRevenue EstRevenue SurpriseRevenue Q2Q
Q3 2025 -0.06 -0.10 41.18% - 123.32K - -
Q2 2025 -0.07 -0.10 27.76% -40.00% 134.6K - -
Q1 2025 -0.06 -0.14 57.98% - - -
Q4 2024 -0.06 -0.06 -6.95% -50.00% - -
Q3 2024 -0.06 -0.06 1.96% -500.00% - -100.00%
Q2 2024 -0.05 -0.06 18.30% 16.67% - -
Q1 2024 -0.06 -0.05 -17.65% 14.29% - -
Q4 2023 -0.04 -0.08 50.98% 33.33% - -
Q3 2023 -0.01 -0.08 87.75% 85.71% 1M - -
Q2 2023 -0.06 -0.07 15.97% 25.00% - -
Q1 2023 -0.07 -0.07 1.96% 23.75% - -
Q4 2022 -0.06 -0.09 30.80% -50.00% - -
Q3 2022 -0.07 -0.09 23.75% - - -100.00%
Q2 2022 -0.08 -0.09 9.51% 11.11% - -
Q1 2022 -0.09 - - - -100.00%
Q4 2021 -0.04 -0.10 57.98% 29.82% - -
Q3 2021 -0.07 -0.09 23.75% 12.50% 40K - -
Q2 2021 -0.09 -0.09 -1.81% 10.00% - -
Q1 2021 0.00 -0.08 100.00% 100.00% 4M - -
Q4 2020 -0.06 -0.09 37.91% - - -
Q3 2020 -0.08 -0.12 34.64% - - -
Q2 2020 -0.10 -0.10 1.96% - - -
Q1 2020 -0.06 -0.08 26.47% - - -

Notes

  • EPS and Revenue values are non-GAAP when available, otherwise GAAP.
  • Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
  • Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
  • Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.

Earnings Q2Q Performance Trends

EPS Historical Q2Q growth and Acceleration

MNOV EPS Q2Q GrowthMNOV EPS Q2Q GrowthEPS Q2Q Growth Q1/21 Q3/21 Q2/22 Q4/22 Q2/23 Q4/23 Q2/24 Q4/24 Q2/25 Q4/25 0 -100 -200 -300 -400

Revenue Historical Q2Q growth and Acceleration

MNOV Revenue Q2Q GrowthMNOV Revenue Q2Q GrowthRevenue Q2Q Growth Q1/22 Q3/22 Q3/24 -20 -40 -60 -80

Surprise distribution (Last 4 Quarters)

EPS beat statistics

EPS beat (4)
3
Average EPS beat (4)
29.99%
Max EPS beat (4)
57.98%
Min EPS beat (4)
-6.95%

Revenue beat statistics

Revenue beat (4)
N/A
Average Revenue beat (4)
N/A
Max Revenue beat (4)
N/A
Min Revenue beat (4)
N/A

Analysis

In the last 4 quarters, MNOV has beaten EPS estimates in 3 out of 4 releases
In the last 4 quarters, MNOV has beaten the EPS estimates by 30.0% on average.
→ Find peers who consistently beat earnings by at least 10% in the last 4 quarters

MEDICINOVA INC / MNOV Earnings FAQ

When did MEDICINOVA INC (MNOV) report earnings last quarter?

MEDICINOVA INC (MNOV) last reported earnings on 2/13/2026.


Did MEDICINOVA INC (MNOV) beat earnings estimates last quarter?

MEDICINOVA INC (MNOV) beat EPS estimates and missed revenue estimates in the most recent quarter.


Can you provide information on how often MEDICINOVA INC beats earnings estimates?

In the last 4 quarters, MEDICINOVA INC (MNOV) has beaten EPS estimates in 3 out of 4 releases.